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Background and objective: It has been shown that peripheral muscle dysfunction is a critical
factor in determining exercise intolerance in patients with several chronic lung diseases,
including idiopathic pulmonary fibrosis. We hypothesized that exercise capacity would be, at
least in part, determined by peripheral muscle dysfunction in patients with fibrotic nonspecific
interstitial pneumonia (f-NSIP), another major subtype of fibrotic interstitial lung disease. The
aim of the current study was to elucidate the relevance of peripheral muscle dysfunction and
its contribution to exercise intolerance in f-NSIP.
Methods: The six-minute walk test was evaluated in 30 consecutive patients with f-NSIP along
with potential determinants of exercise capacity, including respiratory muscle force and
peripheral muscle force.
Results: Among 30 patients, the median age was 61 years, and 21 were female. Sixteen
patients showed significantly decreased quadriceps force (QF), and 17 had significant
decreases in maximum expiratory pressure. Exercise capacity and muscle power were clearly
related to sex. Adjusted for sex, QF showed a significant relation to exercise capacity
measured by six-minute walk distance (6MWD), whereas pulmonary function parameters such
as vital capacity showed marginal correlations. In stepwise multiple regression analysis, only
QF was an independent predictor of 6MWD.61 82 5101; fax: þ81 561 82 9139.
.jp (H. Taniguchi).
3 Elsevier Ltd. All rights reserved.
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QF contributes to exercise capacity in NSIP 623Conclusions: Quadriceps weakness is often observed in patients with f-NSIP. It seems that QF
significantly contributes to exercise capacity in this population.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
The importance of evaluating exercise capacity is widely
recognized in chronic lung diseases. Its clinical relevance
has been intensely investigated especially in patients with
chronic obstructive lung disease, and its impacts on their
prognosis as well as their quality of life have been eluci-
dated.1 More recently, attention is also being directed to
evaluation of exercise capacity in patients with interstitial
lung diseases. Several recent studies have reported that
six-minute walk distance (6MWD) is an independent and
discriminating predictor of mortality among patients clas-
sified as having idiopathic pulmonary fibrosis (IPF).2
Fibrotic nonspecific interstitial pneumonia (f-NSIP) has
been recognized, along with IPF, as one of the major types
of chronic idiopathic interstitial pneumonias.3e5 F-NSIP has
come to be recognized as a distinct disease entity with
characteristic clinical, radiologic, and pathologic features
that differ from other idiopathic interstitial pneumonias.5
However, the number of previous studies that have con-
ducted exercise testing in f-NSIP patients is very limited.2,6
Previously, we reported factors related to exercise
capacity in IPF and demonstrated that quadriceps weakness
was related to exercise capacity.7 However, the determi-
nants of exercise tolerance in interstitial pneumonias other
than IPF remain uncertain.
In considering the mechanisms of exercise limitation in
patients with f-NSIP, we hypothesized that peripheral
muscle weakness may exist in patients with f-NSIP and may
contribute to exercise intolerance. We therefore assessed
exercise tests and respiratory and peripheral muscle func-
tion of patients with f-NSIP along with tests of pulmonary
function to explore the determinants of exercise capacity.
Materials and methods
Study subjects
Consecutive patients with f-NSIP diagnosed at Tosei
General Hospital from April 2003 to March 2011, who con-
sented to the study and underwent subsequent measure-
ments in pulmonary function, exercise capacity and muscle
strength, were retrospectively reviewed. During the study
period a total of 257 cases of interstitial lung diseases were
diagnosed by surgical lung biopsy at this hospital. One
hundred and thirty patients were diagnosed as having
fibrotic idiopathic interstitial pneumonia, and 38 of them
were diagnosed with f-NSIP. The diagnosis of f-NSIP was
confirmed by two lung pathologists. F-NSIP was newly
diagnosed by a physician using the diagnostic criteria in the
ATS/ERS consensus statement.8 Patients who had received
corticosteroids or similar medical treatment prior to the
evaluation were excluded. Patients were also excluded if
they had (1) clinically evident connective tissue disease
(CTD), (2) cardiac disease, (3) obstructive lung disease suchas COPD or asthma, and (4) other pathologic conditions
(arthritis, malignancy, cerebrovascular disease).
This analysis was approved by our local institutional
review board.
Exercise capacity
To evaluate exercise capacity, the current study adopted
the six-minute walk test (6-MWT), a reliable, valid, and
responsive measure of exercise tolerance in patients with
interstitial lung diseases.9 It also has major advantages over
maximal exercise testing in terms of reproducibility in the
routine evaluation of fibrotic interstitial pneumonias.10
The 6-MWT was conducted in all patients who partici-
pated in the study, according to the ATS statement.11
Briefly, all patients were tested under standardized condi-
tions by trained technicians. Baseline heart rate and oxygen
saturation were measured. Patients were instructed to walk
as far as possible in 6 min. The distance the patients could
walk was recorded. Oxygen saturation was monitored and
recorded continuously throughout the test by pulse oxime-
try. No supplemental oxygen was given during the test.
Pulmonary function tests and arterial blood gas
tensions
All patients underwent pulmonary function testing including
lung volumes and spirometry (CHESTAC-55V; Chest; Tokyo,
Japan), according to the method described in the ATS 1994
update.12 Single-breath diffusing capacity of carbonmonoxide
(DLco) was also measured (CHESTACV; Chest). The values for
vital capacity (VC) and DLco were also related to predicted
values. Arterial blood gas tensions were measured at rest.
Respiratory muscle force
Maximal inspiratory pressure (PI max) and maximal expi-
ratory pressure (PE max) were determined in all patients. PI
max was measured at residual volume, and PE max was
measured near total lung capacity, according to the well-
validated method proposed by Black and Hyatt (Vitalo-
power KH-101; Chest).13 The highest value from at least
three maneuvers was recorded. Reproducibility of the
measurements was fairly good.
To determine patients with significant weakness in
respiratory muscle power, the values were related to the
predicted values13 and those less than 80% of the prediction
were considered to be significantly weak.14
Peripheral muscle force
Themeasurements of peripheralmuscle forcesweredonewith
the methodologies well validated in the previous studies.7,15
Hand grip force (HF) was measured with a hydraulic hand
dynamometer (Smedley’s Dynamometer; TTM; Tokyo,
624 F. Watanabe et al.Japan). Peak HF (kg) was assessed with each hand with the
shoulder, elbow and wrist in a neutral position.
Quadriceps force (QF) was measured using a dynamom-
eter (Cybex II; Lumex; Bay Shore, NY). Peak torque
(Newton-m) was measured in both legs during a maximal
isokinetic knee extension maneuver with the hip in 90
flexion. The evaluation was performed in concentric mode
with an angular speed of 60 s. After the practice session,
each patient performed a series of four knee flexions/
extensions on one side of the body and then the other, with
a 15-s rest between the series.
The highest values for HF and QF from at least three
respective maneuvers were recorded. Reproducibility of
both measurements was good.
HF was related to age and sex specific predicted values,16
and less than 80% of prediction was considered to be signif-
icantly weak.17 QF was also related to normal values derived
fromhealthy Japanese subjects, whichwere also age and sex
specific.18 QF less than 1.5 SD below norms were considered
to be significant weakness, according to previous reports.18
Statistics
The data obtained from the 30 patients were analyzed
statistically. All statistical analysis was performed using
SPSS ver.17 (SPSS Inc., Chicago, IL).
The distribution of numeric data was stratified by sex
and examined by Smirnov and Grubbs’s test to detect
possible significant (two-sided p < 0.05) outliers. To
determine factors contributing to exercise performance in
univariate analysis, linear regression models were assessed
with raw 6MWD as the dependent variable and the model
was adjusted for sex. Independent variables assessed in the
model were age, height, weight, pulmonary function
parameters (VC, DLco, PaO2 and PaCO2 assessed by arterial
gas analysis), respiratory and peripheral muscle force (PI
max, PE max, HF, and QF), and minimum SpO2 observed in
exercise testing. In the subsequent multivariate model,
a stepwise multiple regression analysis was performed using
6MWD as a dependent variable, with adjustment either by
sex only or by sex, age, height and weight. Any variable
with p < 0.2 in univariate analysis were introduced in
multivariable models as potential predictors. To avoid
multicollinearity, only one of the highly correlated vari-
ables (coefficient of correlation  0.9) was entered in the
multivariate model, if present.
In determining the factors contributing to QF, univariate
analyses were conducted with all the variables except for
6MWD as independent variables. Subsequent multivariate
analyses were conducted in a similar fashion. Comparisons
between groups were performed using unpaired t-test.
Apvalueof<0.05wasconsideredtobesignificant.All values
are presented as median (range), unless otherwise specified.
Result
Patient characteristics and anthropometric and
pulmonary function data
Of 38 patients diagnosed with f-NSIP, six patients could not
undergo exercise measurements because of a progressiveclinical course, one had severe emphysematous change in
lungs, and one had received corticosteroid therapy prior to
the exercise measurement. These eight patients were
excluded from the analysis. In the end, 30 patients with f-
NSIP who fulfilled the full-set measurements were eligible
for this study. All patients underwent all the measurements
and there were no missing data. A majority of the patients
were female and the median age was 61, although the ages
were widely distributed. As shown in Table 1. There were
significant differences in VC and DLco between males and
females. However the prevalence of impaired VC (<80%
predicted) or DLco (<70% predicted) did not differed
significantly according to sex (male 4/9 versus female 14/
21; p Z 0.43 for VC, male 6/9 versus female 19/21;
p Z 0.14 for DLco). No patients showed resting hypoxemia
in arterial blood gas analysis.
Exercise capacity
The exercise capacity of these patients is also shown in
Table 1. Median 6-MWT distance was 560 m. Male patients
walked longer than female patients (pZ 0.014 in unpaired
t-test). The median of the lowest SpO2 during 6-MWT was
87.5%, showing hypoxemia on exercise. Of all patients, 50%
(15/30 cases) showed exertional desaturation (SpO2<88%)
during 6-MWT. Although some of the patients showed
remarkable desaturation measured by pulse oxymetry
during exercise, all the patients completed the 6 min
walking without any complication and the decreased SpO2
and elevated pulse rate recovered quickly post test.
Muscle testing
Respiratory and peripheral muscle testing results are also
shown in Table 1. There were significant differences
between men and women in all muscle strength measure-
ments (p < 0.01 for QF, HF, PEmax, and PImax). We defined
the thresholds of significant muscle weakness as described
in the Methods. According to these definitions, a majority
of the patients showed significant weakness in PE max (17
of 30 patients) and QF (16 of 30 patients). Meanwhile, only
a minority of the patients had significant weakness in HF (4
patients) and PI max (4 patients).
Explaining factors of exercise capacity
As shown in Table 1, 6MWD as well as muscle strength
differed clearly by sex. Each of the possible contributing
factors for 6MWD were then assessed by linear regression
models adjusted for sex (Table 2). In this univariate analysis
only QF showed a significant relation (bZ 1.030, pZ 0.0282)
to 6MWD, whereas the following parameters showed
marginal significance: PEmax, PaO2 and DLco (p < 0.1); VC,
HF and PImax (p < 0.2). A scatter diagram showing the
correlation between 6MWD and QF is shown in Fig. 1.
To determine the independent predictors of exercise
tolerance, we subsequently conducted a stepwise multiple
regression analysis for 6MWD adjusted by gender. In this
model, QF was the only independent determinant of 6MWD.
The total variance explained by this model was 32%
(p < 0.01) (Table 3, Model 1). In general, 6MWD is known to
Table 1 Patient characteristics.
All Men Female
No 30 9 21
Age, yrs 61(34e75) 62(36e69) 59(34e75)
Height, cm 155.4(145.4e172.7) 166.5(159.7e172.7) 153.4 (145.4e159.2)
Weight, kg 59.9(41.5e84.4) 65(60.5e75) 54(41.5e84.4)
VC, L 1.96(1.03e4.48) 3.02(1.93e4.48) 1.70(1.03e2.91)
VC, %predicted 75.4(41.7e110.6) 87.5(57.1e110.6) 71.7(41.7e100.0)
DLco, mL/min/mmHg 8.8(2.4e28.8) 11.4(4.8e28.8) 8.4 (2.4e15.3)
DLco, % predicted 52.2(15.5e107.8) 63(25.9e107.8) 49.9 (15.5e87.6)
PaO2, mmHg 81.4(62.4e96.8) 81.2(62.4e89.6) 81.4 (64.6e96.8)
PaCO2, mmHg 40.8(34.1e49.4) 39.4(34.1e49.4) 41.0(35.9e44.7)
6MWD, m 560(333e710) 610(500e710) 545(333e660)
Lowest SpO2 during test, % 87.5(58e97) 86.0(58e95) 88.0(70e97)
PI max, cmH2O 95.1(34.1e181.2) 132.1(76.1e181.2) 82.5(34.1e151.5)
PI max, %predicted 117.0(51.5e194.3) 118.8(69.5e163.1) 115.2(51.5e194.3)
PE max, cmH2O 123.3(53.4e243.8) 189.4(126.9e243.8) 105.2(53.4e190.2)
PE max, % predicted 75.3(40.8e141.2) 94.2(61.9e107.4) 74.8(40.8e141.2)
HF, kg 24.8(10.0e49.5) 39.3(32.5e49.5) 22.3(10e36.5)
HF, %predicted 96.6(50.5e131.1) 98.9(74.4e131.1) 94.7(50.5e114.2)
QF, Nm 83.3(45e236) 148.5(77.5e236) 74.5(45e110)
QF, %predicted 82.0(49.7e139.5) 106.2(55.4e139.5) 81.8(49.7e114.9)
Values are expressed as median (range) unless otherwise indicated.
SpO2: percutaneous oxygen saturation. PI max: maximal inspiratory pressure, PE max: maximal expiratory pressure, HF: hand grip force,
QF: quadriceps force, Nm: Newton-meter.
QF contributes to exercise capacity in NSIP 625be related to age, height and weight. We subsequently
assessed themultiple regression models with adjustment for
sex, age, height and weight. In the latter model also, QF was
proven to be the sole independent determinant of 6MWD
among all the parameters. The total variance explained by
this model was up to 55% (p < 0.05) (Table 3, Model 2).
Discussion
In the present study, we conducted simultaneous assess-











PI max 0.832 0.1127
PE max 0.704 0.0718
HF 4.452 0.1227
QF 1.030 0.0282
Lowest SpO2 during test 2.250 0.2525
Models were adjusted for sex.muscle strength in 30 patients with f-NSIP to elucidate the
determining factors for exercise capacity. We found that
reduced PEmax and QF were often observed in patients
with f-NSIP. Moreover, QF is the sole factor contributing
significantly to exercise capacity according to our multi-
variate analysis. To our knowledge, this is the first report
clarifying the relationship between peripheral muscle
performance and exercise capacity in patients with f-NSIP.
Peripheral muscle dysfunction in COPD has been well
characterized. Previous report by Gosselink et al. revealedFigure 1 Correlations between six-minute walk distance
and QF.
Table 3 Result of stepwise multiple regression analysis




Model 1: Adjusted for sex
QF, Nm 1.030 0.444 0.486 0.028
Sex, male 22.589 41.765 0.113 0.593
Model 2: Adjusted for sex, age, height and weight
QF, Nm 1.771 0.505 0.835 0.002
Sex, male 118.371 53.124 0.594 0.035
Age 0.988 1.644 0.104 0.554
Height 9.235 4.902 0.743 0.033
Weight 2.032 1.607 0.245 0.218
Model 1: R2 Z 0.32, p Z 0.005.
Model 2: R2 Z 0.55, p Z 0.01.
626 F. Watanabe et al.that lower limb muscles are affected to a greater extent
than are upper limb muscles. In their report, QF was
correlated significantly with six-minute walking distance.19
Recently, Mainguy et al. demonstrated that decreased
quadriceps strength was correlated with impaired exercise
capacity in patients with idiopathic pulmonary arterial
hypertension.20 We have previously reported on the rela-
tionship between exercise capacity and peripheral muscle
performance of IPF.7 Our current result in f-NSIP was
consistent with these previous reports of other chronic lung
diseases, suggesting a generalized process.
Determinants of exercise limitation in patients with
interstitial lung diseases (ILD) have been explored. An early
study by Burdon et al. reported that decreased exercise
capacity was correlated with VC in patients with ILD.21
Hansen and Wasserman reported that DLco was the best
correlate of exercise capacity, from a retrospective review
of 43 ILD patients.22 In these studies, however, patients’
diagnoses included IPF, sarcoidosis, hypersensitivity pneu-
monitis, and some other diseases.
Despite these previous studies, the pathophysiology of
the exercise limitation in ILD has not been fully elucidated.
Moreover, studies that investigated the mechanisms of
exercise limitation in patients with ILD generally included
a variety of diseases. It seems likely that the factors
determining exercise limitation depend on the etiologies of
ILD. In a study that enrolled only IPF patients, we previously
revealed that QF is one of the main determinants of exer-
cise capacity. Recently, Caminati et al. also reported
moderate correlations between 6MWD and both percent
predicted FVC and percent predicted DLco.23
To our knowledge, however, there has been no study on
exercise capacity in patients with f-NSIP. Additionally, the
evaluation of peripheral muscle strength in this study more
clearly demonstrated the determinants of exercise capacity
in f-NSIP. Thus, our current evaluation seems valuable.
Our current results revealed that quadriceps muscle
weakness was frequently observed and related to exercise
limitation in f-NSIP patients. This was consistent with
previous observation in an IPF cohort. It is assumed that
there are several possible factors and mechanisms that
cause peripheral muscle dysfunction in ILD.About half of the patients in this study showed exer-
tional desaturation. Hypoxia is known to increase the
oxidative stress that may adversely affect the performance
of muscle.24,25 Thus hypoxia might be a mechanism that
adversely affects skeletal muscle and exercise capacity. To
test this hypothesis, we also conducted an analysis to
explore the determinants of QF (supplemental table). In
univariate analysis there were several factors related to QF.
In the subsequent stepwise multivariate analysis, DLco
appeared to be one of the independent explaining factors
for QF. It is supposed that dysfunction in lung parenchyma is
relevant to peripheral muscle weakness in patients with f-
NSIP; nevertheless, factors more directly related to
hypoxia, such as PaO2 and SpO2 during exercise, did not
show significant relations.
The inflammatory disease process is also thought to be
related to quadriceps weakness, as NSIP is characterized by
inflammatory cell infiltration in lung interstitium. Decon-
ditioning due to limitation in activities of daily living might
be another mechanism of impairment in the quadriceps
muscles. Interestingly, aberrant TGF-b signaling was impli-
cated in a model of atrophic muscle caused by hypoxia,
inflammation and disuse.26 TGF-b is known to play a critical
role in the pathogenesis of fibrotic lung diseases, and it
might be supposed that this molecule also affects periph-
eral muscles in this population. Unfortunately we did not
perform muscle biopsy, but further insights will be obtained
if this is done in future study.
In the current study we excluded patients with history of
corticosteroid use to avoid possible effects on peripheral
muscle weakness. Because CTD is a common complication in
NSIP patients and may affect exercise performance as well
as peripheral muscle weakness, patients with CTD were also
excluded from the analysis. Moreover, patients with
a coexisting disorder that might affect QF were excluded
from the cohort in order to eliminate possible confounders.
Muscle weakness is known to be related to age, as
a 25e30 percent decrease in muscle mass is observed in the
seventh decade of life in humans.24 Therefore we also
assessed the multivariate model with the adjustment for
age. Thus, we tried to eliminate possible confounding
factors that would affect quadriceps weakness. However,
the underlying pathophysiology of the weakness of the QF is
unknown even in IPF. Clearly, additional research will be
necessary to elucidate the pathophysiology of the muscle
weakness in NSIP.
Measurement of pulmonary function and exercise
indices is integral to the assessment and monitoring of
patients with IPF and may also provide useful prognostic
information and facilitate treatment decisions.27,28
The 6-MWT is a widely used measure of exercise toler-
ance in patients with various cardiac and pulmonary
diseases. A couple of recent controlled trials provided
support for the benefits of pulmonary rehabilitation in
subjects with IPF and ILD.29,30 We previously reported
significant improvements in 6MWD in subjects with IPF.29
Holland et al. also found significant improvements in
6MWD following rehabilitation, in a randomized controlled
trial of 57 subjects with ILD.30 The consistent finding that
peripheral muscle strength was correlated with exercise
capacity in patients with f-NSIP, as well as in IPF patients,
raised an intriguing question. Will training of peripheral
QF contributes to exercise capacity in NSIP 627muscles, especially in the lower extremities, increase the
exercise capacity of patients with f-NSIP? Further study on
exercise capacity is warranted in patients with f-NSIP.
Some limitations of this study should be mentioned.
First, this was a retrospective and cross-sectional study.
Second, the study involved a so small number of patients
from one center that we could not make a definitive
conclusion. Future study including larger sample size, if
possible, may make the conclusion robust. In addition, the
patients involved in the study consisted entirely of Japa-
nese. It is unclear whether the present results can be
adapted to other ethnic groups. Multiregional prospective
studies would be able to eliminate ethnic bias and other
possible bias. As there are no available normal values and/
or lower limits for HF and respiratory muscle force in
Japanese’ subjects to our knowledge, it is possible that we
did not evaluate the severity of muscle impairment
observed in this cohort accurately, except for QF.
In conclusion, we explored the determinants of exercise
capacity in 30 consecutive f-NSIP patients. Decreased QF
was frequently observed and shown to be an independent
predictor of exercise capacity in multivariate analysis. From
the current results, it seems that peripheral muscle weak-
ness may be related to exercise intolerance in this pop-
ulation. Further study regarding the therapeutic response to
peripheral muscle training is warranted in this population.
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